company background image
PBH

Prestige Consumer Healthcare NYSE:PBH Stock Report

Last Price

US$61.58

Market Cap

US$3.0b

7D

-2.0%

1Y

8.9%

Updated

08 Dec, 2022

Data

Company Financials +
PBH fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance4/6
Financial Health3/6
Dividends0/6

PBH Stock Overview

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally.

Prestige Consumer Healthcare Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Prestige Consumer Healthcare
Historical stock prices
Current Share PriceUS$61.58
52 Week HighUS$63.91
52 Week LowUS$48.51
Beta0.59
1 Month Change8.42%
3 Month Change18.15%
1 Year Change8.86%
3 Year Change57.94%
5 Year Change34.87%
Change since IPO246.93%

Recent News & Updates

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Recent updates

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jun 14
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Apr 19
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

How Much Did Prestige Consumer Healthcare's (NYSE:PBH) CEO Pocket Last Year?

Feb 22
How Much Did Prestige Consumer Healthcare's (NYSE:PBH) CEO Pocket Last Year?

Prestige Consumer Healthcare's(NYSE:PBH) Share Price Is Down 17% Over The Past Five Years.

Feb 01
Prestige Consumer Healthcare's(NYSE:PBH) Share Price Is Down 17% Over The Past Five Years.

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Jan 11
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Read This Before Judging Prestige Consumer Healthcare Inc.'s (NYSE:PBH) ROE

Dec 21
Read This Before Judging Prestige Consumer Healthcare Inc.'s (NYSE:PBH) ROE

Are Investors Undervaluing Prestige Consumer Healthcare Inc. (NYSE:PBH) By 40%?

Nov 30
Are Investors Undervaluing Prestige Consumer Healthcare Inc. (NYSE:PBH) By 40%?

Shareholder Returns

PBHUS PharmaceuticalsUS Market
7D-2.0%-0.3%-2.8%
1Y8.9%14.1%-19.6%

Return vs Industry: PBH underperformed the US Pharmaceuticals industry which returned 13.4% over the past year.

Return vs Market: PBH exceeded the US Market which returned -21.2% over the past year.

Price Volatility

Is PBH's price volatile compared to industry and market?
PBH volatility
PBH Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement11.0%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: PBH is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: PBH's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996535Ron Lombardihttps://www.prestigebrands.com

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief.

Prestige Consumer Healthcare Inc. Fundamentals Summary

How do Prestige Consumer Healthcare's earnings and revenue compare to its market cap?
PBH fundamental statistics
Market CapUS$3.05b
Earnings (TTM)US$208.60m
Revenue (TTM)US$1.11b

14.6x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PBH income statement (TTM)
RevenueUS$1.11b
Cost of RevenueUS$475.27m
Gross ProfitUS$632.47m
Other ExpensesUS$423.88m
EarningsUS$208.60m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)4.21
Gross Margin57.10%
Net Profit Margin18.83%
Debt/Equity Ratio88.8%

How did PBH perform over the long term?

See historical performance and comparison